A 208 LEU 20 -16.684 -17.066
A 209 SER 3 -17.820 -16.116
A 210 ALA 16 -21.300 -20.691
A 211 LYS 0 -19.663 -17.402
A 212 ASP 9 -17.961 -16.931
A 213 LEU 29 -22.883 -23.586
A 214 ALA 20 -23.182 -22.816
A 215 LEU 5 -19.286 -17.643
A 216 LEU 22 -19.334 -19.640
A 217 LEU 40 -22.360 -24.389
A 218 PHE 15 -19.662 -19.126
A 219 THR 9 -15.996 -15.191
A 220 HIS 27 -17.351 -18.461
A 221 LEU 24 -17.346 -18.112
A 222 PRO 6 -11.261 -10.656
A 223 GLY 13 -10.363 -10.666
A 224 ASN 1 -10.935 -9.793
A 225 ASN 10 -12.447 -12.165
A 226 THR 17 -15.335 -15.527
A 227 PRO 22 -17.237 -17.785
A 228 PHE 19 -20.591 -20.408
A 229 HIS 15 -20.660 -20.009
A 230 ILE 29 -20.552 -21.524
A 231 LEU 36 -23.195 -24.667
A 232 ALA 28 -24.842 -25.205
A 233 GLN 12 -23.055 -21.783
A 234 VAL 36 -23.051 -24.540
A 235 LEU 41 -24.891 -26.743
A 236 SER 19 -24.774 -24.110
A 237 LYS 15 -22.820 -21.921
A 238 ILE 28 -22.546 -23.173
A 239 ALA 31 -21.872 -22.922
A 240 TYR 16 -20.114 -19.641
A 241 LYS 14 -16.650 -16.345
A 242 SER 20 -16.115 -16.562
A 243 GLY 0 -15.552 -13.764
A 244 LYS 17 -18.222 -18.081
A 245 SER 17 -20.868 -20.423
A 246 GLY 2 -18.015 -16.173
A 247 ALA 13 -17.884 -17.322
A 248 PHE 37 -21.531 -23.310
A 249 LEU 20 -20.756 -20.669
A 250 ASP 7 -17.753 -16.517
A 251 ALA 24 -18.692 -19.303
A 252 PHE 27 -20.452 -21.205
A 253 HIS 9 -17.112 -16.179
A 254 GLN 10 -14.828 -14.273
A 255 ILE 21 -15.852 -16.444
A 256 LEU 15 -15.122 -15.108
A 257 SER 6 -11.784 -11.119
A 258 GLU 15 -10.629 -11.131
A 259 GLY 0 -9.800 -8.673
A 260 GLU 16 -11.991 -12.452
A 261 ASN 8 -14.768 -13.990
A 262 ALA 24 -18.726 -19.332
A 263 GLN 10 -18.900 -17.876
A 264 ALA 9 -17.080 -16.150
A 265 ALA 27 -20.759 -21.477
A 266 LEU 30 -22.790 -23.619
A 267 THR 12 -20.103 -19.171
A 268 ARG 18 -18.914 -18.809
A 269 LEU 33 -22.194 -23.437
A 270 SER 33 -21.610 -22.919
A 271 ARG 12 -17.614 -16.968
A 272 THR 12 -17.178 -16.583
A 273 PHE 34 -19.361 -21.045
A 274 ASP 6 -16.020 -14.868
A 275 ALA 29 -19.125 -20.261
A 276 PHE 32 -20.741 -22.036
A 277 MET 6 -15.292 -14.223
A 278 GLY 1 -12.304 -11.004
A 279 VAL 27 -16.850 -18.017
A 280 VAL 10 -14.565 -14.040
A 281 PRO 34 -17.574 -19.463
A 282 PRO 17 -16.984 -16.986
A 283 VAL 10 -11.534 -11.357
A 284 ILE 29 -12.224 -14.153
A 285 ARG 1 -6.931 -6.249
A 286 VAL 23 -5.296 -7.332
A 287 LYS 4 -2.282 -2.480 <=B
A 288 ASN 2 -2.323 -2.286 <=B
A 289 PHE 18 -3.471 -5.141
A 290 GLN 3 -2.437 -2.502 <=B
A 291 THR 10 -3.935 -4.632
A 292 VAL 28 -7.047 -9.457
A 293 PRO 21 -8.416 -9.863
A 294 ARG 2 -6.095 -5.624
A 295 PRO 11 -7.242 -7.674
A 296 CYS 30 -10.746 -12.960
A 297 GLN 10 -6.318 -6.742
A 298 LYS 9 -4.992 -5.453
A 299 SER 21 -8.670 -10.088
A 300 LEU 21 -8.169 -9.644
A 301 ARG 17 -6.379 -7.601
A 302 ALA 2 -5.488 -5.087
A 303 VAL 16 -7.176 -8.190
A 304 PRO 20 -6.775 -8.296
A 305 PRO 0 -4.862 -4.303
A 306 ASN 4 -7.416 -7.024
A 307 PRO 21 -9.831 -11.116
A 308 THR 13 -15.550 -15.257
A 309 ILE 29 -19.626 -20.704
A 310 ASP 10 -17.105 -16.288
A 311 LYS 16 -14.604 -14.765
A 312 GLY 11 -17.064 -16.367
A 313 TRP 22 -16.226 -16.890
A 314 VAL 28 -19.801 -20.744
A 315 CYS 27 -17.274 -18.393
A 316 VAL 17 -12.670 -13.168
A 317 TYR 24 -8.668 -10.431
A 318 SER 8 -5.872 -6.116
A 319 SER 16 -3.720 -5.133
A 320 GLU 4 -1.931 -2.169 <=B
A 321 GLN 6 -1.577 -2.086 <=B
A 322 GLY 0 -2.826 -2.501 <=B
A 323 GLU 12 -3.513 -4.489
A 324 THR 16 -5.828 -6.997
A 325 ARG 21 -6.467 -8.138
A 326 ALA 18 -11.381 -12.142
A 327 LEU 35 -14.310 -16.690
A 328 LYS 13 -13.027 -13.024
A 329 ILE 29 -16.452 -17.895

Identified 6 B-Cell epitope residues out of 122 total residues